Q4 2023 Orthopedic Sales Comparison Among the Big Three: Stryker, Zimmer Biomet, and Johnson & Johnson

Source: Bone Future; Editor: Yang Liurong

Reprint Requirements: You can directly republish, but please credit the source at the beginning of the article.

• Total Sales: $5.8 Billion (Increased by 11.8%)
• Orthopedics Sales: $2.4 Billion (Increased by 11%)
• Hip Joint Sales: $414 million (Increased by 10.2%)
• Knee Joint Sales: $630 Million (Increased by 14.2%)
• Spine Sales: $318 Million (Increased by 7%)

• Total Sales: $1.9 Billion (Increased by 6.3%)
• Hip Joint Sales: $504.8 Million (Increased by 3.3%)
• Knee Joint Sales: $798.3 Million (Increased by 5.9%)
• Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Chest Sales: $453.3 million (Increased by 6.9%)

• Total Sales: $21.4 billion (increased by 7.3%)
• Spine, Sports and Other Sales: $742 Million (Increased by 6.2%)
• Orthopedic Sales: $2.3 Billion (Increased by 5.6%)
• Hip Joint Sales: $398 Million (Increased by 3.4%)
• Knee Joint Sales: $387 Million (Increased by 9.2%)

Stryker

Stryker's orthopedic and spine businesses can be further divided intoKnee Joint、Hip Joint、Trauma and Extremities、SpineAndOther. (For details, see: "Seizing Johnson & Johnson's Market? Stryker Releases Latest Earnings Report: 145.6 Billion!》）

By growth rateKnee joint (13.9%) > Trauma and limbs (12.1%) > Hip joint (9.2%) > Others (7.1%) > Spine (3.8%);

By Net Sales: Trauma and Extremities (3.15 billion) > Knee (2.27 billion) > Hip (1.54 billion) > Spine (1.19 billion) > Others (5.09 billion).

Zimmer Biomet

The main products of Zimmer Biomet include knee joints, hip joints, and others (ExerciseMedicine, Limbs, Trauma, Craniomaxillofacial and Thoracic）(For details, see: "Zimmer Biomet Announces Financial Results for the Fourth Quarter and Full Year 2023!）